Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting ...Middle East

Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular Biopharmaceutical Group Ltd. (the Company, or Shanghai Cellular Bio), a company engaged in the drug...

Hence then, the article about shanghai cellular biopharmaceutical group presents first data from phase i trial evaluating a novel car t in advanced liver cancer at aacr annual meeting was published today ( Monday 17/04/2023 - 11:24 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting )

Also on site :

• Contractor that cut back ancient oak in London park identified
• Jennifer Siebel Newsom’s Parenting Tips Include Dolls for Boys and Gender-Swapping Male Book Characters
• Myanmar’s coup leader elected president by pro-military parliament